Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

New turnkey research facility will provide AAALAC-accredited flexible vivarium space for Massachusetts biopharmaceutical hub

WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) has announced the opening of a new Charles River Accelerator and Development Lab (CRADL®) facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub. The facility is strategically co-located with Nest.Bio, a provider of rentable BSL-2 laboratory and office space. The Chestnut Street location will address an increased demand for more flexible vivarium and bench space, as well as on-demand in vivo study support services within the heart of Massachusetts’ industry-leading biopharmaceutical sector.


“We are excited to bring CRADL to Somerville’s Brickbottom District, an emerging life science hub for biotech development in which startups unable to find lab space in the increasingly crowded Cambridge environment can thrive,” said Colin Dunn, Ph.D., Corporate Senior Vice President, Global Research Models & Services, Charles River. “CRADL’s scalable contract vivarium space, combined with Charles River’s extensive preclinical network, supports clients in starting projects quickly, without the costly burden of building infrastructure.”

CRADL® is the leading space for clients to launch or expand their drug research programs, with the added benefit of access to Charles River’s complete portfolio of integrated drug discovery and non-clinical development resources.

The new Somerville facility is strategically situated less than a mile from the established industry presence in Kendall Square. The building offers a unique coexistence of private lab suites, rentable lab benches, and office space on the same floor to enable seamless communication, collaboration, and productivity. This distinctive setup can be particularly advantageous for startup organizations, providing an efficient and streamlined environment for both research and administrative functions.

Expanding Access and Expertise to Global Ecosystems through CRADL

With the addition of a fourth Massachusetts site, the CRADL Vivarium Network operates nearly 30 facilities in key biohubs, including: San Francisco, San Diego, Seattle, Philadelphia, Chicago, Thousand Oaks, Shanghai, Chengdu and London. This network supports the growth of the entire biotech ecosystem in each city, allowing researchers to rapidly engage in their research while maintaining the flexibility to relocate or co-locate, knowing they will have reliable, high-quality facilities nearby.

Charles River is hosting a grand opening for CRADL Somerville on July 31, 2024, including guided tours and equipment demonstrations with expert staff. To learn more and register, visit: https://www.criver.com/education-training/cradlr-somerville-grand-opening-co-located-bench-office-space.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Contacts

Investor Contact:
Todd Spencer

Corporate Vice President,

Investor Relations

781.222.6455

[email protected]

Media Contact:
Amy Cianciaruso

Corporate Vice President,

Chief Communications Officer

781.222.6168

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.